2,108
Views
0
CrossRef citations to date
0
Altmetric
HPV

Parental willingness of HPV vaccination in Mainland China: A meta-analysis

, , , , , ORCID Icon, & show all
Article: 2314381 | Received 21 Aug 2023, Accepted 01 Feb 2024, Published online: 22 Feb 2024

References

  • Human Papillomavirus Vaccines. WHO position paper, May 2017. Wkly Epidemiol Rec. 2017;92(19):241–12. PMID: 28530369.
  • de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):180–90. doi:10.1016/S2214-109X(19)30488-7. PMID: 31862245.
  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660. PMID: 33538338.
  • Rahangdale L, Mungo C, O’Connor S, Chibwesha CJ, Brewer NT. Human papillomavirus vaccination and cervical cancer risk. BMJ. 2022;379:e070115. doi:10.1136/bmj-2022-070115. PMID: 36521855.
  • Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, Burger EA, Martin D, Nguyen DTN, Bénard É, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet. 2020;395(10224):591–603. doi:10.1016/s0140-6736(20)30157-4. PMID: 32007142.
  • Kamolratanakul S, Pitisuttithum P. Human papillomavirus vaccine efficacy and effectiveness against cancer. Vaccines (Basel). 2021;9(12):1413. doi:10.3390/vaccines9121413. PMID: 34960159.
  • Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Sparén P. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020;383(14):1340–1348. doi:10.1056/NEJMoa1917338. PMID: 32997908.
  • World Health Organization. Global partners cheer progress towards eliminating cervical cancer and underline challenges; [accessed 2023 Dec 28]. https://www.who.int/news/item/17-11-2023-global-partners-cheer-progress-towards-eliminating-cervical-cancer-and-underline-challenges.
  • Yu XD. Evaluation of HPV-related cognition and the health education of HPV in junior high school students [ thesis]. Wuhan (CN): Huazhong University of Science and Technology; 2017.
  • Smith PJ, Stokley S, Bednarczyk RA, Orenstein WA, Omer SB. HPV vaccination coverage of teen girls: the influence of health care providers. Vaccine. 2016;34(13):1604–1610. doi:10.1016/j.vaccine.2016.01.061. PMID: 26854907.
  • Bruni L, Saura-Lázaro A, Montoliu A, Brotons M, Alemany L, Diallo MS, Afsar OZ, LaMontagne DS, Mosina L, Contreras M, et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019. Prev Med. 2021;144:106399. doi:10.1016/j.ypmed.2020.106399. PMID: 33388322.
  • Zeng XT, Liu H, Chen X. Meta-analysis series IV: a quality assessment tool for observational studies. Chin J Evidence-Based Cardiovasc Med. 2012;4(4):297–9.
  • Agency for Healthcare Research and Quality (US). Celiac disease (evidence reports/technology assessments, No. 104): AHRQ evidence reports; [accessed 2023 May 10]. https://www.ncbi.nlm.nih.gov/books/NBK35156/.
  • Zhang SK, Pan XF, Wang SM, Yang CX, Gao XH, Wang ZZ, Li M, Ren ZF, Zhao FH, Qiao YL. Perceptions and acceptability of HPV vaccination among parents of young adolescents: a multicentre national survey in China. Vaccine. 2013;31(32):3244–9. doi:10.1016/j.vaccine.2013.05.046. PMID: 23707446.
  • Hu HS, Wei XL, Ren ZF, Zeng XM, Zhao FH, Qiao YL. Investigation on acceptance of HPV vaccination and its determinants among the parents of junior high school students in Guangzhou City. Chin J Dise Control. 2014;18(7):659–62.
  • Zhang H, Yu DX, Liu ZX, Shaoming W, Yang X, Yuehua P, Dongming W, Jincong Y, Weiquan W. Parental acceptance of junior high school students for human papillomavirus vaccination: a survey at one school in Wuhan. Public Health Prev Med. 2014;25(1):49–52.
  • Wang W, Ma Y, Wang X, Zou H, Zhao F, Wang S, Zhang S, Zhao Y, Marley G, Ma W. Acceptability of human papillomavirus vaccine among parents of junior middle school students in Jinan, China. Vaccine. 2015;33(22):2570–2576. doi:10.1016/j.vaccine.2015.04.010. PMID: 25887088.
  • Yu Y, Xu M, Sun J, Li R, Li M, Wang J, Zhang D, Xu A, Liu X. Human papillomavirus infection and vaccination: awareness and knowledge of HPV and acceptability of HPV vaccine among mothers of teenage daughters in Weihai, Shandong, China. PLoS One. 2016;11(1):e0146741. doi:10.1371/journal.pone.0146741. PMID: 26766565.
  • Zheng CY. Immunogenicity, safety and residents’ awareness of HPV vaccine in real world [ thesis]. Fujian (CN): Xiamen University; 2016. doi:10.27424/d.cnki.gxmdu.2021.003094.
  • Hu TJ, Zhu Q, Chen WH, Shen J, Gu S, Shen J, Lu H. Survey on knowledge of human HPV and HPV vaccine, acceptance for vaccination and its influence factors among parents of elementary and middle school students in Songjiang district of Shanghai city. Chin J Viral Dis. 2018;8(3):216–22. doi:10.16505/j.2095-0136.2018.0026.
  • Pu C, Liu CY, Zhang X, Jing LI. Knowledge and attitudes toward HPV and its vaccines among parents of middle school students in Chengdu. Mod Prev Med. 2018;45(2):299–302+347.
  • Han YF, Zhuang YN, Li Y, Fang Y. Analysis of mothers’ acceptance of HPV vaccination of adolescent girls in Xiamen. Chin J Prev Med. 2018;52(1):38–42. doi:10.3760/cma.j.issn.0253-9624.2018.01.008.
  • Deng JJ, Zhang J, Wang J, Liu N, Zhang Y, Xu J, Luan L. Investigation on the cognition of prevention and control of cervical cancer in parents of primary and secondary schools in Suzhou. Public Health Prev Med. 2019;30(5):138–41. doi:10.3969/j.issn.1006-2483.2019.05.035.
  • Wu ZF, Qian XH, Hu JY. Willingness of mothers to vaccinate their primary-school-age girls with human papillomavirus vaccine and factors influencing willingness in a district of Shanghai. Chin Vacc Immun. 2020;26(6):634–8. doi:10.19914/j.cjvi.2020.06.006.
  • Fu SL. Knowledge and attitudes toward prophylactic human papillomavirus (HPV) vaccines among the mainland Chinese population [ thesis]. Beijing (CN): Peking Union Medical College Cancer Hospital, Chinese Academy of Medical Sciences; 2020. doi:10.27648/d.cnki.gzxhu.2019.000626.
  • Zhong XH. GSK GZ’s HPV vaccine public cognition survey and communication strategy research [ thesis]. Guangdong (CN): South China University of Technology; 2020. doi:10.27151/d.cnki.ghnlu.2019.004668.
  • He JL, Hong LJ, Liu YX. Knowledge about human papillomavirus (HPV) and HPV vaccine and willingness for their children′s vaccination among parents of 9-14-years old girls in Hangzhou city. China Public Health. 2022;36(10):1478–81.
  • Wang BH, Yan SY, Wang SY, Wu SY, Tao QQ, Gao HH, Shen QX, Hui LI, Yuan CZ, Zhang X, et al. Awareness of HPV and HPV vaccine and willingness to be vaccinated among parents of children aged 9-14. Public Health Prev Med. 2023;34(1):39–43. doi:10.3969/j.issn.1006-2483.2023.01.009.
  • Lin Y, Su Z, Chen F, Zhao Q, Zimet GD, Alias H, He S, Hu Z, Wong LP. Chinese mothers’ intention to vaccinate daughters against human papillomavirus (HPV), and their vaccine preferences: a study in Fujian Province. Hum Vaccin Immunother. 2021;17(1):304–15. doi:10.1080/21645515.2020.1756152. PMID: 32401617.
  • Zhu S, Chang J, Hayat K, Li P, Ji W, Fang Y. Parental preferences for HPV vaccination in junior middle school girls in China: a discrete choice experiment. Vaccine. 2020;38(52):8310–8317. doi:10.1016/j.vaccine.2020.11.020. PMID: 33223307.
  • Zhao CY, Shi J, Zhang GF, Cui M, Wang Y, Liu Z, Liu C, Niu T, Jia J, Luo L. Acceptance of HPV vaccination by mothers of primary and secondary school girls and its influencing factors in Tongzhou District, Beijing. China School Health. 2020;41(4):597–600. doi:10.16835/j.cnki.1000-9817.2020.04.031.
  • Huang Y, Xu S, Xu Y, Yao D, Wang L, Zhao Y, Wu Q. A new strategy for cervical cancer prevention among Chinese women: how much do they know and how do they react toward the HPV immunization? J Cancer Educ. 2021;36(2):386–394. doi:10.1007/s13187-019-01642-y. PMID: 31902089.
  • Liang H, Tand TT, Lu HK, Chen Y, Pan X, Ding L, Hu X., Wang Y Awareness and willingness to vaccinate daughters with human papillomavirus vaccines among parents of primary and middle school students. Prev Med. 2021;33(9):884–8. doi:10.19485/j.cnki.issn2096-5087.2021.09.005.
  • Xie Y, Su LY, Wang F, Tang HY, Yang QG, Liu YJ. Awareness regarding and vaccines acceptability of human papillomavirus among parents of middle school students in Zunyi, Southwest China. Hum Vaccin Immunother. 2021;17(11):4406–4411. doi:10.1080/21645515.2021.1951931. PMID: 34324411.
  • Shi JJ. Current survey on guardians’ acceptance of HPV vaccination for girls aged 9-14 in four provinces [ thesis]. Beijing (CN): Centre for Immunization, Chinese Centre for Disease Control and Prevention; 2021. doi:10.27511/d.cnki.gzyyy.2020.000028.
  • Huang Z, Ji M, Ren J, Sun X, Boulton ML, Zikmund-Fisher BJ, Wagner AL. Effect of the framing of HPV vaccination on parents’ willingness to accept an HPV vaccine. Vaccine. 2022;40(6):897–903. doi:10.1016/j.vaccine.2021.12.051. PMID: 34996644.
  • Zheng ZZ, Li MF, Wu QS, Chen MS, Zhao CJ. Investigation on the willingness of mothers to vaccinate their daughters against HPV vaccine in a community in Haikou City. Electron J Mod Med Health Res. 2022;6(17):108–12.
  • Yun XX, Wang DH, Tan HF, Ni LH, Zhong ML, Chen Q. Study on HPV vaccination willingness of junior middle school girls’ guardians and factors in Guangzhou. Med Anim Prev. 2022;38(7):663–6.
  • Zhang R, Gao LJ, Ma W, Ni MJ. Willingness toward human papillomavirus vaccination and the related factors among parents of junior high school students: a nationwide survey in China. Asian J Surg. 2023;46(3):1358–1360. doi:10.1016/j.asjsur.2022.08.115. PMID: 36127196.
  • Zhang Z, Shi J, Zhang X, Guo X, Yu W. Willingness of parents of 9-to-18-year-old females in China to vaccinate their daughters with HPV vaccine. Vaccine. 2023;41(1):130–135. doi:10.1016/j.vaccine.2022.11.016. PMID: 36411136.
  • Zhong WJ, Duan JF, Wang ZY, Xiang J, Tian J, Pan J. Perception of HPV and the willingness of HPV vaccine among parents of female pupils in Qingpu District,Shanghai City. China Public Health Management. 2022;38(1):68–72. doi:10.19568/j.cnki.23-1318.2022.01.0016.
  • Xie H, Zhu HY, Jiang NJ, Yin YN. Awareness of HPV and HPV vaccines, acceptance to vaccination and its influence factors among parents of adolescents 9 to 18 years of age in China: a cross-sectional study. J Pediatr Nurs. 2023;71:73–78. doi:10.1016/j.pedn.2023.03.007. PMID: 37028228.
  • Guo Q, Zhou W, Wen X, Lu J, Lu X, Lu Y. Discrepancy of human papillomavirus vaccine uptake and intent between girls 9-14 and their mothers in a pilot region of Shanghai, China. Hum Vaccin Immunother. 2022;18(6):2132801. doi:10.1080/21645515.2022.2132801. PMID: 36306482.
  • Song QQ, Zhang YH, Wen DR, Mei MA, Liang R, Xin YA, Xiuzhen WA. Current situation and influencing factors of HPV vaccine hesitancy among parentsof primary and secondary school girls in Guangyuan. Public Health Prev Med. 2023;34(3):114–18.
  • Li M, Ju LR, Li BL, Liu F, Zhou JY, Qi Q. Survey of the cognition on human papillomavirus and it’s preventive vaccine of junior schoolstudents’ parents and university students in Beijing. Chin J Woman Child Health Res. 2013;24(1):14–7, 60. doi:10.3969/j.issn.1673-5293.2013.01.006.
  • Qiu LR. To investigate the status and influencing factors of HPVvaccination of 9~14 years old female within small areas [ thesis]. Shan Xi (CN): Shanxi Medical University; 2021.
  • Mabeya H, Odunga J, Broeck DV. Mothers of adolescent girls and human papilloma virus (HPV) vaccination in Western Kenya. Pan Afr Med J. 2021;38:126. doi:10.11604/pamj.2021.38.126.21359. PMID: 33912296.
  • Waller J, Forster A, Ryan M, Richards R, Bedford H, Marlow L. Decision-making about HPV vaccination in parents of boys and girls: a population-based survey in England and Wales. Vaccine. 2020;38(5):1040–1047. doi:10.1016/j.vaccine.2019.11.046. PMID: 31787415.
  • Azh N, Hosseinzadeh K, Javadi A, Gholami-Toranposhti S. Factors predicting mothers’ intention toward human papilloma virus vaccination of adolescents: a cross-sectional study among Iranian families. Iran J Nurs Midwifery Res. 2021;26(6):495–9. doi:10.4103/ijnmr.IJNMR_313_20. PMID: 34900647.
  • Akca G, Akca U. Turkish mothers’ knowledge and attitude about HPV vaccine. J Pediatr Nurs. 2022;67:83–87. doi:10.1016/j.pedn.2022.08.011. PMID: 36041253.
  • Alhusayn KO, Alkhenizan A, Abdulkarim A, Sultana H, Alsulaiman T, Alendijani Y. Attitude and hesitancy of human papillomavirus vaccine among Saudi parents. J Family Med Prim Care. 2022;11(6):2909–2916. doi:10.4103/jfmpc.jfmpc_2377_21. PMID: 36119278.
  • Marić G, Birčanin Đ, Kisić V, Dotlić J, Zarić M, Kisić-Tepavčević D, Gazibara T. Parental perspective on human papillomavirus (HPV) vaccination in Serbia: knowledge, attitudes and practice. Sex Reprod Healthc. 2018;16:192–198. doi:10.1016/j.srhc.2018.04.010. PMID: 29804766.
  • Islam JY, Khatun F, Alam A, Sultana F, Bhuiyan A, Alam N, Reichenbach L, Marions L, Rahman M, Nahar Q. Knowledge of cervical cancer and HPV vaccine in Bangladeshi women: a population based, cross-sectional study. BMC Womens Health. 2018;18(1):15. doi:10.1186/s12905-018-0510-7. PMID: 29325530.
  • Ganczak M, Owsianka B, Korzeń M. Factors that predict parental willingness to have their children vaccinated against HPV in a country with low HPV vaccination coverage. Int J Envir Res Pub Health. 2018;15(4):645. doi:10.3390/ijerph15040645. PMID: 29614733.
  • Sypień P, Zielonka TM. Knowledge and awareness of polish parents on vaccination against human papillomavirus. Vaccines (Basel). 2022;10(7):1156. doi:10.3390/vaccines10071156. PMID: 35891319.
  • Akinleye HW, Kanma-Okafor OJ, Okafor IP, Odeyemi KA. Parental willingness to vaccinate adolescent daughters against human papilloma virus for cervical cancer prevention in Western Nigeria. Pan Afr Med J. 2020;36:112. doi:10.11604/pamj.2020.36.112.19007. PMID: 32821323.
  • Ohareri B, Adefolaju AO, Onyeneho CA. Knowledge, attitudes and perceptions of Nigerian parents towards human papilloma virus (HPV) vaccines. Eur J Midwifery. 2020;4:2. doi:10.18332/ejm/114886. PMID: 33537604.
  • Rabiu KA, Alausa TG, Akinlusi FM, Davies NO, Shittu KA, Akinola OI. Parental acceptance of human papillomavirus vaccination for adolescent girls in Lagos, Nigeria. J Family Med Prim Care. 2020;9(6):2950–2957. doi:10.4103/jfmpc.jfmpc_102_20. PMID: 32984154.
  • Jia C, Long Y, Luo X, Li X, Zuo W, Wu Y. Inverted U-shaped relationship between education and family health: the urban-rural gap in Chinese dual society. Front Public Health. 2022;10:1071245. doi:10.3389/fpubh.2022.1071245. PMID: 36711367.
  • Bai Y, Ip P, Chan K, Ngan H, Yip P. HPV vaccination intentions of female students in Chinese universities: a systematic literature review and meta-analysis. Int J Envir Res Pub Health. 2022;19(16):10207. doi:10.3390/ijerph191610207. PMID: 36011838.
  • Kolek CO, Opanga SA, Okalebo F, Birichi A, Kurdi A, Godman B, Meyer JC. Impact of parental knowledge and beliefs on HPV vaccine hesitancy in Kenya—findings and implications. Vaccines (Basel). 2022;10(8):1185. doi:10.3390/vaccines10081185. PMID: 35893833.
  • Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, Ehlen T, Dobson S, Money D, et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med. 2010;7(5):e1000270. doi:10.1371/journal.pmed.1000270. PMID: 20454567.
  • Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis. 2004;8(3):188–194. doi:10.1097/00128360-200407000-00005. PMID: 15874862.
  • Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007;40(2):108–115. doi:10.1016/j.jadohealth.2006.10.007. PMID: 17259050.
  • Teng GP, Jin SH . On the group effect of college students’ self-esteem on trust. Chin J Spec Educ. 2015;178(4):84–88.
  • Barlow FK, Hornsey MJ, Thai M, Sengupta NK, Sibley CG, Costantini M. The wallpaper effect: the contact hypothesis fails for minority group members who live in areas with a high proportion of majority group members. PLoS One. 2013;8(12):e82228. doi:10.1371/journal.pone.0082228. PMID: 24349227.
  • Sonawane K, Zhu Y, Montealegre JR, Lairson DR, Bauer C, McGee LU, Giuliano AR, Deshmukh AA. Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey. Lancet Public Health. 2020;5(9):e484–e492. doi:10.1016/s2468-2667(20)30139-0. PMID: 32707126.
  • Rositch AF, Liu T, Chao C, Moran M, Beavis AL. Levels of parental human papillomavirus vaccine hesitancy and their reasons for not intending to vaccinate: insights from the 2019 national immunization survey-teen. J Adolesc Health. 2022;71(1):39–46. doi:10.1016/j.jadohealth.2022.01.223. PMID: 35279361.
  • Degarege A, Krupp K, Fennie K, Srinivas V, Li T, Stephens DP, Madhivanan P. An integrative behavior theory derived model to assess factors affecting HPV vaccine acceptance using structural equation modeling. Vaccine. 2019;37(7):945–955. doi:10.1016/j.vaccine.2019.01.012. PMID: 30655176.
  • Attia AC, Wolf J, Núñez AE. On surmounting the barriers to HPV vaccination: we can do better. Ann Med. 2018;50(3):209–225. doi:10.1080/07853890.2018.1426875. PMID: 29316825.
  • Shelton RC, Snavely AC, De Jesus M, Othus MD, Allen JD. HPV vaccine decision-making and acceptance: does religion play a role? J Relig Health. 2013;52(4):1120–1130. doi:10.1007/s10943-011-9553-x. PMID: 22076049.
  • Kjaer SK, Nygård M, Dillner J, Brooke Marshall J, Radley D, Li M, Munk C, Hansen BT, Sigurdardottir LG, Hortlund M, et al. A 12-year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 nordic countries. Clin Infect Dis. 2018;66(3):339–345. doi:10.1093/cid/cix797. PMID: 29029053.
  • Basu P, Malvi SG, Joshi S, Bhatla N, Muwonge R, Lucas E, Verma Y, Esmy PO, Poli URR, Shah A, et al. Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study. Lancet Oncol. 2021;22(11):1518–1529. doi:10.1016/S1470-2045(21)00453-8. PMID: 34634254.
  • Goldstone SE, Giuliano AR, Palefsky JM, Lazcano-Ponce E, Penny ME, Cabello RE, Moreira ED, Baraldi E, Jessen H, Ferenczy A, et al. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis. 2022;22(3):413–425. doi:10.1016/S1473-3099(21)00327-3. PMID: 34780705.
  • Drolet M, Laprise JF, Martin D, Jit M, Bénard É, Gingras G, Boily MC, Alary M, Baussano I, Hutubessy R, et al. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis. Lancet Infect Dis. 2021;21(11):1598–1610. doi:10.1016/s1473-3099(20)30860-4. PMID: 34245682.
  • You T, Zhao X, Hu S, Gao M, Liu Y, Zhang Y, Qiao Y, Jit M, Zhao F. Optimal allocation strategies for HPV vaccination introduction and expansion in China accommodated to different supply and dose schedule scenarios: A modelling study. EClinicalMedicine. 2023;56:101789. doi:10.1016/j.eclinm.2022.101789. PMID: 36618898.
  • Song YF, Liu XX, Yin ZD, Yu W, Cao L, Cao L, Ye J, Li L, Wu J. Human papillomavirus vaccine coverage among the 9-45-year-old female population of China in 2018-2020. Chin J Vacc Immun. 2021;27(5):570–5. doi:10.19914/j.CJVI.2021101.
  • Morbidity and Mortality Weekly Report. Vaccination coverage among adolescents aged 13–17 years — national immunization survey–teen, United States; 2022 [accessed 2023 Jan 23]. https://www.cdc.gov/mmwr/volumes/72/wr/mm7234a3.htm.
  • Dib F, Mayaud P, Renaudie C, Launay O, Chauvin P. Determinants of human papillomavirus (HPV) vaccine uptake among girls in France: a population-based telephone survey. Hum Vaccin Immunother. 2022;18(5):2083894. doi:10.1080/21645515.2022.2083894. PMID: 35766886.
  • Khosa LA, Meyer JC, Motshwane FMM, Dochez C, Burnett RJ. Vaccine hesitancy drives low human papillomavirus vaccination coverage in girls attending public schools in South Africa. Front Public Health. 2022;10:860809. doi:10.3389/fpubh.2022.860809. PMID: 35685759.
  • Ampofo AG, Mackenzie L, Boyes AW. HPV vaccination: intention to participate among female senior high school students in Ghana. Vaccine. 2023;41(1):159–169. doi:10.1016/j.vaccine.2022.11.007. PMID: 36411133.
  • Azuogu BN, Umeokonkwo CD, Azuogu VC, Onwe OE, Okedo-Alex IN, Egbuji CC. Appraisal of willingness to vaccinate daughters with human papilloma virus vaccine and cervical cancer screening uptake among mothers of adolescent students in Abakaliki, Nigeria. Niger J Clin Pract. 2019;22(9):1286–1291. doi:10.4103/njcp.njcp_452_18. PMID: 31489868.
  • Vu M, Yu J, Awolude OA, Chuang L. Cervical cancer worldwide. Curr Probl Cancer. 2018;42(5):457–465. doi:10.1016/j.currproblcancer.2018.06.003. PMID: 30064936.
  • Lin W, Wang Y, Liu Z, Chen B, Yuan S, Wu B, Gong L. Inequalities in awareness and attitude towards HPV and its vaccine between local and migrant residents who participated in cervical cancer screening in Shenzhen, China. Cancer Res Treat. 2020;52(1):207–217. doi:10.4143/crt.2019.053. PMID: 31291712.
  • Yuen WWY, Lee A, Chan PKS, Tran L, Sayko E, Grce M. Uptake of human papillomavirus (HPV) vaccination in Hong Kong: facilitators and barriers among adolescent girls and their parents. PLoS One. 2018;13(3):e0194159. doi:10.1371/journal.pone.0194159. PMID: 29543839.